How International Standards for Molecular Biomarker Testing in Lung Cancer Have Influenced Which Tests are Routinely PerformedVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Roy Herbst and David Rimm discuss the 50-gene panel that has become an ISLC-mandated standard for all patients with lung cancer; however, the components of cancer biomarker testing panels must be fluid and respond to new developments in the field as reported in the literature and/or at international cancer meetings, with adoption of the test predicated on standardization and the perceived value of the test.
Description: Dr. Boccia describes cases in which he uses CancerTREATMENT NGS+ in his clinical practice.
Atheer Kaddis, SVP Sales/Business Development of Diplomat Specialty Pharmacy, describes in his opinion how specialty pharmacy can assist patients with polycythemia veraSupported through funding from Incyte